AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32360666 — intervention group
Group type: COMPARATOR
Intervention: Copper-T380A intrauterine device (IUD)
Number of subjects: 789
Study 35717995 — intervention group
Group type: EXPERIMENTAL
Intervention: BBV152 (COVAXIN); two 0.5 mL intramuscular doses on days 0 and 28.
Number of subjects: 526
Study 34183570 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) with wrap fixation (suturing the wrap to the diaphragmatic crura or to the body of stomach)
Number of subjects: 102
Study 34183570 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication (LNF) without wrap fixation
Number of subjects: 102
Study 33207158 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based violence intervention programs (HVIPs)
Number of subjects: 0
Study 33207158 — intervention group
Group type: COMPARATOR
Intervention: Standard emergency department care without HVIP
Number of subjects: 0
Study 36256502 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Neuromodulation (TN)
Number of subjects: 56
Study 36256502 — intervention group
Group type: COMPARATOR
Intervention: Sham TN
Number of subjects: 56
Study 34038632 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate kangaroo mother care
Number of subjects: 3211
Study 34038632 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (incubator or radiant warmer until stabilization)
Number of subjects: 3211
Study 32441471 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain Breakfast
Number of subjects: 0
Study 32441471 — intervention group
Group type: COMPARATOR
Intervention: Sugar-Sweetened Breakfast
Number of subjects: 0
Study 35379563 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0
Study 35379563 — intervention group
Group type: COMPARATOR
Intervention: Platinum-based doublet chemotherapy (standard care)
Number of subjects: 0
Study 33125466 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgyny (high masculinity and high femininity)
Number of subjects: 301
Study 33125466 — intervention group
Group type: COMPARATOR
Intervention: Gender roles
Number of subjects: 301
Study 32928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed
Number of subjects: 11007
Study 32928754 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics prescribed
Number of subjects: 11007
Study 32928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed for men aged 15 to 24 years
Number of subjects: 11007
Study 32928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed for men aged 25 to 34 years
Number of subjects: 11007
Study 32928754 — intervention group
Group type: EXPERIMENTAL
Intervention: General risk of PTA following RTI consultation
Number of subjects: 11007
Study 33543874 — intervention group
Group type: EXPERIMENTAL
Intervention: ICR plus CXL
Number of subjects: 35
Study 33543874 — intervention group
Group type: COMPARATOR
Intervention: ICR only
Number of subjects: 35
Study 33543874 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 32365732 — intervention group
Group type: EXPERIMENTAL
Intervention: capsules with starch-adsorbed VitD (1000 IU; 25 µg daily)
Number of subjects: 105
Study 32365732 — intervention group
Group type: EXPERIMENTAL
Intervention: oil-based Valens VitD oral spray (1000 IU; 25 µg daily)
Number of subjects: 105
Study 32365732 — intervention group
Group type: EXPERIMENTAL
Intervention: water-based Valens VitD oral spray (1000 IU; 25 µg daily)
Number of subjects: 105
Study 32365732 — intervention group
Group type: COMPARATOR
Intervention: control group (no supplemental VitD)
Number of subjects: 105
Study 33413519 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 199
Study 33413519 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 199
Study 32298717 — intervention group
Group type: EXPERIMENTAL
Intervention: DMAU (dimethandrolone undecanoate)
Number of subjects: 57
Study 32298717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 32298717 — intervention group
Group type: EXPERIMENTAL
Intervention: DMAU
Number of subjects: 57
Study 32298717 — intervention group
Group type: EXPERIMENTAL
Intervention: DMAU and Placebo
Number of subjects: 57
Study 35035867 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided stellate ganglion block
Number of subjects: 36
Study 35035867 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy
Number of subjects: 36
Study 35035867 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Ultrasound-guided stellate ganglion block + Extracorporeal shock wave therapy)
Number of subjects: 36
Study 32024486 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise protocol (AEP)
Number of subjects: 56
Study 32024486 — intervention group
Group type: COMPARATOR
Intervention: Delayed start 6-week placebo-like stretching protocol (SP) followed by AEP
Number of subjects: 56
Study 34100975 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable sutures (Vicryl)
Number of subjects: 195
Study 34100975 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable sutures (Ethibond)
Number of subjects: 195
Study 32594522 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg
Number of subjects: 327
Study 32594522 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab 300 mg
Number of subjects: 327
Study 34890104 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit (ACT-based smartphone application)
Number of subjects: 554
Study 34890104 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide (USCPG-based smartphone application)
Number of subjects: 554
Study 34890104 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 554
Study 34890104 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 554
Study 32003150 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPA + SAXA
Number of subjects: 1163
Study 32003150 — intervention group
Group type: COMPARATOR
Intervention: INS
Number of subjects: 1163
Study 35830132 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of ascorbic acid (two days after irrigation treatment)
Number of subjects: 0
Study 35830132 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of mycorrhiza fungus with Azospirillium
Number of subjects: 0
Study 35830132 — intervention group
Group type: COMPARATOR
Intervention: Non-consumption of biological fertilizers
Number of subjects: 0
Study 33591346 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Strength Training
Number of subjects: 377
Study 33591346 — intervention group
Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 377
Study 33591346 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Strength Training
Number of subjects: 377
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis for frequent recurrent bleeding
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin trials
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet agents and anticoagulant therapy
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Target VWF and factor VIII activity levels for major surgery
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to reduce bleeding during minor surgery or invasive procedures
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Management options for heavy menstrual bleeding
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of VWD in the context of neuraxial anesthesia during labor and delivery
Number of subjects: 0
Study 33570647 — intervention group
Group type: EXPERIMENTAL
Intervention: Management in the postpartum setting
Number of subjects: 0
Study 36436541 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscopy with supplemental oxygen (1 L/Kg per min)
Number of subjects: 250
Study 36436541 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy with supplemental oxygen (1 L/Kg per min)
Number of subjects: 250
Study 36436541 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Video laryngoscopy and Direct laryngoscopy)
Number of subjects: 250
Study 33955229 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure treatment (<120 mm Hg)
Number of subjects: 8584
Study 33955229 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (<140 mm Hg)
Number of subjects: 8584
Study 34304615 — intervention group
Group type: EXPERIMENTAL
Intervention: 19 F bidirectional cannula (Biflow™, LivaNova, Italy)
Number of subjects: 64
Study 34304615 — intervention group
Group type: COMPARATOR
Intervention: 19 F conventional cannula (HLS Peripheral cannula, Getinge Group™, Germany)
Number of subjects: 64
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: National cancer registration for ovarian/tubal/peritoneal cancer
Number of subjects: 3110
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: Death registration for tubo-ovarian cancer
Number of subjects: 3110
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple electronic health record sources for cancer site
Number of subjects: 3110
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple electronic health record sources for cause of death
Number of subjects: 3110
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer registration accuracy
Number of subjects: 3110
Study 33494753 — intervention group
Group type: EXPERIMENTAL
Intervention: Death registration accuracy
Number of subjects: 3110
Study 35763045 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking at moderate intensity (40-60% of age-adjusted maximal heart rate), three times per week for 12 weeks
Number of subjects: 49
Study 35763045 — intervention group
Group type: COMPARATOR
Intervention: Electronic lectures on diet, diabetes, and mental health
Number of subjects: 49
Study 33000539 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant therapy
Number of subjects: 124
Study 33000539 — intervention group
Group type: COMPARATOR
Intervention: Control (non-sealed teeth)
Number of subjects: 124
Study 32960955 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum bell therapy and physiotherapy
Number of subjects: 26
Study 32960955 — intervention group
Group type: COMPARATOR
Intervention: Vacuum bell treatment only
Number of subjects: 26
Study 35501676 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular, one 30 s ARM (RARMs)
Number of subjects: 252
Study 35501676 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved and intermittent, three 10s ARMs (IARMs)
Number of subjects: 252
Study 35501676 — intervention group
Group type: COMPARATOR
Intervention: Control (C), no ARMs
Number of subjects: 252
Study 32249637 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified anti-inflammatory diet
Number of subjects: 100
Study 32249637 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet recommendations (Control)
Number of subjects: 100
Study 32349429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin biscuits (20% lupin)
Number of subjects: 20
Study 32349429 — intervention group
Group type: COMPARATOR
Intervention: Wholemeal spelt biscuits
Number of subjects: 20
Study 32349429 — intervention group
Group type: COMPARATOR
Intervention: Standard plain sweet biscuits
Number of subjects: 20
Study 35499204 — intervention group
Group type: EXPERIMENTAL
Intervention: SM-88 Regimen (460 or 920 mg daily with methoxsalen, phenytoin, and sirolimus)
Number of subjects: 49
Study 34360036 — intervention group
Group type: COMPARATOR
Intervention: Diet control group (D)
Number of subjects: 66
Study 34360036 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet control plus elastic band exercise group (D + E)
Number of subjects: 66
Study 35168531 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg
Number of subjects: 120
Study 35168531 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg
Number of subjects: 120
Study 35168531 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5 mg followed by combination treatment with bisoprolol 5 mg and amlodipine 5 mg
Number of subjects: 120
Study 35168531 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (2.5 mg - 5 mg - 10 mg)
Number of subjects: 120
Study 35168531 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with bisoprolol and amlodipine
Number of subjects: 120
Study 35168531 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study 33819336 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft from the palate after deepithelialization (DE)
Number of subjects: 0
Study 33819336 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft obtained with parallel incision (PI)
Number of subjects: 0
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of inferior facial angle (IFA)
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of maxilla-nasion-mandible (MNM) angle
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of facial maxillary angle (FMA)
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of profile line (PL) distance
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of IFA
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of MNM angle
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of FMA
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurement of PL distance
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of IFA with crown-rump length (CRL)
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PL distance with crown-rump length (CRL)
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of MNM angle with crown-rump length (CRL)
Number of subjects: 380
Study 33894762 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of FMA with crown-rump length (CRL)
Number of subjects: 380
Study 35576345 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI < 25
Number of subjects: 6058
Study 35576345 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 40 or higher
Number of subjects: 6058
Study 35576345 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 5-unit increase in BMI
Number of subjects: 6058
Study 35483994 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM)
Number of subjects: 0
Study 35483994 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 33954851 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Pain (GP)
Number of subjects: 64
Study 33954851 — intervention group
Group type: COMPARATOR
Intervention: Group Strain (GS)
Number of subjects: 64
Study 32690858 — intervention group
Group type: EXPERIMENTAL
Intervention: Various clinical and pathological factors analyzed using SPSS to predict overall survival (OS)
Number of subjects: 266
Study 35574874 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 0
Study 35574874 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes fatalism
Number of subjects: 0
Study 35574874 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes knowledge
Number of subjects: 0
Study 34280656 — intervention group
Group type: EXPERIMENTAL
Intervention: PICS classification models
Number of subjects: 289
Study 34280656 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher age and longer duration of ICU treatment and mechanical ventilation
Number of subjects: 289
Study 34280656 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender and higher age
Number of subjects: 289
Study 36149935 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-1
Number of subjects: 44
Study 36149935 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-21
Number of subjects: 44
Study 36149935 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-23
Number of subjects: 44
Study 36149935 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-423-5-p
Number of subjects: 44
Study 36149935 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 44
Study 34156521 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free sirolimus-eluting stent (PF-SES)
Number of subjects: 3002
Study 34156521 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer zotarolimus-eluting stent (DP-ZES)
Number of subjects: 3002
Study 33034360 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartSurfACE transepithelial PRK
Number of subjects: 2
Study 33034360 — intervention group
Group type: COMPARATOR
Intervention: Streamlight transepithelial PRK
Number of subjects: 2
Study 35969440 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational module completion (central intervention component)
Number of subjects: 27
Study 35969440 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational module completion
Number of subjects: 27
Study 35969440 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of meditations
Number of subjects: 27
Study 35969440 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the stress meter
Number of subjects: 27
Study 34787258 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus verapamil (n=26)
Number of subjects: 32
Study 34787258 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=6)
Number of subjects: 32
Study 32388647 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic (LA) injection into the suprascapular notch
Number of subjects: 34
Study 32388647 — intervention group
Group type: EXPERIMENTAL
Intervention: LA and corticosteroid (CS) injections into the suprascapular notch
Number of subjects: 34
Study 32388647 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (LA injection into the trapezius muscle)
Number of subjects: 34
Study 35028918 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone mirroring-based telepresence exercise program (20-40 min, 3 times a week for 12 weeks)
Number of subjects: 29
Study 35028918 — intervention group
Group type: COMPARATOR
Intervention: Control group performing the same exercise program at the senior citizen center
Number of subjects: 29
Study 33024268 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI ± bev reintroduction
Number of subjects: 0
Study 33024268 — intervention group
Group type: COMPARATOR
Intervention: Doublets ± bev or other treatments
Number of subjects: 0
Study 34981666 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg amlodipine besylate tablets (generic formulation) in fasting trial
Number of subjects: 56
Study 34981666 — intervention group
Group type: COMPARATOR
Intervention: 5-mg amlodipine besylate tablets (original formulation) in postprandial trial
Number of subjects: 56
Study 34981666 — intervention group
Group type: COMPARATOR
Intervention: Fasting condition
Number of subjects: 56
Study 34981666 — intervention group
Group type: COMPARATOR
Intervention: Postprandial condition
Number of subjects: 56
Study 34981666 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety assessment throughout the study
Number of subjects: 56
Study 33485731 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 88
Study 33485731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 32069857 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate morning-intake (HCM)
Number of subjects: 12
Study 32069857 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate morning-intake (LCM)
Number of subjects: 12
Study 35144698 — intervention group
Group type: EXPERIMENTAL
Intervention: HM plus HM lyophilisate (LioNeo)
Number of subjects: 40
Study 35144698 — intervention group
Group type: COMPARATOR
Intervention: HM plus commercial additive (HMCA)
Number of subjects: 40
Study 36419133 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger feeding
Number of subjects: 99
Study 36419133 — intervention group
Group type: EXPERIMENTAL
Intervention: Cup feeding
Number of subjects: 99
Study 36419133 — intervention group
Group type: EXPERIMENTAL
Intervention: Syringe feeding
Number of subjects: 99
Study 32618279 — intervention group
Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via standard regimen (weeks 0 and 4)
Number of subjects: 36
Study 32618279 — intervention group
Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via accelerated regimen (weeks 0 and 2)
Number of subjects: 36
Study 32618279 — intervention group
Group type: EXPERIMENTAL
Intervention: ZPIV vaccine (5 μg) via single-dose regimen (week 0)
Number of subjects: 36
Study 32618279 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study 35953563 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivized Adherence and Abstinence monitoring (I‐AAM)
Number of subjects: 141
Study 35953563 — intervention group
Group type: COMPARATOR
Intervention: treatment‐as‐usual (control)
Number of subjects: 141
Study 33602468 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 22
Study 33602468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 35164772 — intervention group
Group type: COMPARATOR
Intervention: Core implementation strategies
Number of subjects: 177
Study 35164772 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced implementation strategies
Number of subjects: 177
Study 33724305 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 209
Study 33724305 — intervention group
Group type: COMPARATOR
Intervention: Conventional 7+3 chemotherapy
Number of subjects: 209
Study 35035849 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined etomidate-ketamine anesthesia (etomidate 0.3 mg/kg + ketamine 0.5 mg/kg at 5 μg/kg/min)
Number of subjects: 100
Study 35035849 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined etomidate-ketamine anesthesia
Number of subjects: 100